Keating, G.M. (2011) Fenofibrate: A Review of Its Lipid-Modifying Effects in Dyslipidemia and Its Vascular Effects in Type 2 Diabetes Mellitus. American Journal of Cardiovascular Drugs, 11, 227-247.
http://dx.doi.org/10.2165/11207690-000000000-00000

has been cited by the following article:

• TITLE: Moderate Hypertriglyceridemia Revealed by Acute Chest Syndrome, a Milky Appearance Serum and Prior History of Recurrent Acute Pancreatitis in a Type 2 Diabetes Black Patient: A Case Report

  AUTHORS: François Bompeka Lepira, Vita Eulethère Kintoki, Jean-Robert Risassi Makulo, Fabien Mbala Kintoki

  KEYWORDS: Moderate Hypertriglyceridemia, Acute Chest Syndrome, Pancreatitis, Fibrates, Black African

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.6 No.11, November 30, 2016

  ABSTRACT: Although the “triglyceride paradox” states that hypertriglyceridemia is less frequent in Blacks and the risk of pancreatitis increases with severe hypertriglyceridemia, we herein report on a case of moderate hypertriglyceridemia revealed by an acute chest syndrome and a milky appearance serum in a 47-year-old type 2 diabetes black patient with prior history of recurrent acute pancreatitis. In addition to insulin therapy and coronary angioplasty, the combination of a statin and a fibrate resulted two months later in a substantial improvement in triglyceride levels and a normal serum appearance.